Tag: clinical trials
-
Samsung, Biotech Partner on mRNA Vaccine Production
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA.
-
Trial Advances Test of Electronic Cancer Treatment
A clinical trial completed enrollment of lung cancer patients testing a device sending an electric field into their tumors to disrupt cancer cell proliferation.
-
Cell Therapy Start-Up Raises $6M in Seed Funds
A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding.
-
Trial Identifies Biomarkers for Quick Concussion Test
A clinical trial reveals glycan compounds found in saliva and urine as indicators of traumatic brain injury, helping create a quick diagnostic for the condition.
-
Trial Shows Psilocybin Drug Helps Reduce Depression
A clinical trial shows a drug derived from the hallucinogenic compound psilocybin reduces symptoms of depression, when part of a therapy program.
-
Trial Shows Wearable Device Reduces Migraine Symptoms
Results from a clinical trial show a smartphone-wearable system relieves pain and reduces other symptoms in adult patients with chronic migraine.
-
FDA Halts Off-the-Shelf T-Cell Cancer Trials
The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction.
-
Synthetic Antibody Company Goes Public in $230M Merger
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger.
-
Trial Begins Testing RNA Therapy for Alcohol Disorder
A clinical trial is underway testing a therapy that silences genes to create reactions in people with alcohol use disorder to help them stop drinking.
-
Covid-19 Nasal Spray Vaccine Trial Underway
A clinical trial testing the safety of a Covid-19 vaccine from an engineered virus found in dogs and given as a nasal spray enrolled its first participant.